Pluribus Labs’s Honeywell HON Stock Holding History

Pluribus Labs’s Portfolio HON Stock Details HON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$867K	Buy	5,292 +2,782	+111%	+$500K	1.58%	14
2022 Q1	$460K	Buy	2,510 +1,009	+67%	+$187K	1.83%	13
2021 Q4	$295K	Buy	+1,501	New	+$303K	0.31%	136

Other funds holding HON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pluribus Labs's HON Position: Q2 2022 in Review

Pluribus Labs increased its Honeywell (HON) stake by 111% in Q2 2022, buying an estimated $500K and bringing the position to 5,292 shares worth $867K. The position accounts for 1.58% of the portfolio, ranked #14.

Pluribus Labs first reported a position in HON in Q4 2021 and has held it in 3 quarters since. 2,208 funds tracked by Wall St. Rank hold HON as of Q2 2022.

Pluribus Labs held 5,292 shares of Honeywell worth $867K as of Q2 2022.
Pluribus Labs bought 2,782 Honeywell shares in Q2 2022, an estimated $500K.
Honeywell made up 1.58% of Pluribus Labs's portfolio in Q2 2022, its #14 holding.
Pluribus Labs first reported a position in Honeywell in Q4 2021 and has held it in 3 quarters since.
2,208 funds tracked by Wall St. Rank held Honeywell as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.